Thus, dedifferentiation may also serve to alleviate the biosynthetic burdens on beta cells and promote ‘beta cell rest’ – a clinical concept that explains why suppressing endogenous insulin secretion with exogenous insulin in newly-diagnosed T1D patients ultimately reduces their long-term exogenous insulin requirements (76). This evidence concerns the gene INS and type 1 diabetes mellitus.